Suppr超能文献

澳大利亚医疗保健从业者使用实时处方监测工具的障碍和促进因素。

Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia.

机构信息

School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia.

出版信息

Front Public Health. 2023 Sep 12;11:1175791. doi: 10.3389/fpubh.2023.1175791. eCollection 2023.

Abstract

INTRODUCTION

Real time prescription monitoring tools have been implemented in Australia to address the growing concerns of drug misuse, drug-related mortality and morbidity. The objective of this pilot study is to investigate the barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools.

METHODS

An online survey was distributed to Australian prescribers and pharmacists who use a real time prescription monitoring tool. Data analysis included descriptive statistics, chi-square tests and multivariate logistic regression analyses.

RESULTS

A total of 102 questionnaires were analyzed. Practitioners mainly agreed that the tool was easy to use ( = 64; 66.7%) and access ( = 56; 57.7%), and the data was easy to interpret ( = 77; 79.4%). Over half agreed that they wanted training to guide clinical actions ( = 52; 55.9%) and clinical guidelines or guidance on what to do with the RTPM findings ( = 51; 54.8%). Prescribers were more likely to report difficulties with workplace access to a computer or the internet ( = 7; 21.2%) compared with pharmacists ( 6; 9.2%; 0.037). Practitioners working in community settings ( = 59; 57.9%;  = 0.022) and those with 1-10 years practice experience ( = 45; 44.2%;  = 0.036) were more likely to want training to guide clinical actions in response to RTPM information.

CONCLUSION

This is the first known study to investigate the barriers and facilitators related to practitioner use of RTPM tools in Australia. The results from this study can inform further research to gain an understanding of healthcare practitioners use of RTPM tools, and how to minimize barriers and optimize use for the essential delivery of quality healthcare.

摘要

简介

为了解决药物滥用、与药物相关的死亡率和发病率不断上升的问题,澳大利亚已经实施了实时处方监控工具。本试点研究的目的是调查与医疗保健从业者使用实时处方监控工具相关的障碍和促进因素。

方法

向使用实时处方监控工具的澳大利亚开处方者和药剂师分发了在线调查。数据分析包括描述性统计、卡方检验和多变量逻辑回归分析。

结果

共分析了 102 份问卷。从业者主要同意该工具易于使用(=64;66.7%)和访问(=56;57.7%),并且数据易于解释(=77;79.4%)。超过一半的人同意他们希望接受培训以指导临床行动(=52;55.9%)和有关如何使用 RTPM 结果的临床指南或指导(=51;54.8%)。与药剂师(=6;9.2%;0.037)相比,开处方者更有可能报告在工作场所访问计算机或互联网方面存在困难(=7;21.2%)。在社区环境中工作的从业者(=59;57.9%;=0.022)和具有 1-10 年实践经验的从业者(=45;44.2%;=0.036)更希望接受培训以指导针对 RTPM 信息的临床行动。

结论

这是第一项已知的研究,旨在调查与澳大利亚从业者使用 RTPM 工具相关的障碍和促进因素。本研究的结果可以为进一步研究提供信息,以了解医疗保健从业者对 RTPM 工具的使用情况,以及如何最小化障碍并优化使用,以提供高质量的医疗保健。

相似文献

1
Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia.
Front Public Health. 2023 Sep 12;11:1175791. doi: 10.3389/fpubh.2023.1175791. eCollection 2023.
2
Healthcare practitioner use of real-time prescription monitoring tools: an online survey.
Aust Health Rev. 2023 Apr;47(2):208-216. doi: 10.1071/AH22257.
3
: Healthcare practitioner use of real-time prescription monitoring tools: an online survey.
Aust Health Rev. 2023 Aug;47(4):520. doi: 10.1071/AH22257_CO.
4
Health-care practitioner use of prescription drug monitoring programs in clinical practice in Australia: A qualitative study.
Drug Alcohol Rev. 2023 Nov;42(7):1647-1657. doi: 10.1111/dar.13711. Epub 2023 Jul 4.
5
Pharmacists' perceptions on real-time prescription monitoring (RTPM) systems - a cross-sectional survey.
Explor Res Clin Soc Pharm. 2022 Mar 2;5:100122. doi: 10.1016/j.rcsop.2022.100122. eCollection 2022 Mar.
7
Prescription Drug Monitoring Programs and Pharmacist Orientation Toward Dispensing Controlled Substances.
Subst Use Misuse. 2018 Jul 3;53(8):1324-1330. doi: 10.1080/10826084.2017.1408650. Epub 2018 Jan 3.
8
Provider beliefs on the Barriers and Facilitators to Prescription Monitoring Programs and Mandated Use.
Subst Use Misuse. 2020;55(1):1-11. doi: 10.1080/10826084.2019.1648512. Epub 2019 Aug 19.
9
Prescriber and pharmacist attitudes toward inclusion of diagnosis or clinical indication on prescription orders.
J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4):e284-e288. doi: 10.1016/j.japh.2020.12.015. Epub 2021 Feb 6.
10
Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists.
Int J Clin Pharm. 2023 Apr;45(2):421-429. doi: 10.1007/s11096-022-01523-3. Epub 2022 Dec 17.

引用本文的文献

1
Pan-European survey on medication adherence management by healthcare professionals.
Br J Clin Pharmacol. 2024 Dec;90(12):3135-3145. doi: 10.1111/bcp.16183. Epub 2024 Jul 27.

本文引用的文献

1
Healthcare practitioner use of real-time prescription monitoring tools: an online survey.
Aust Health Rev. 2023 Apr;47(2):208-216. doi: 10.1071/AH22257.
2
Mapping the research addressing prescription drug monitoring programs: A scoping review.
Drug Alcohol Rev. 2022 May;41(4):803-817. doi: 10.1111/dar.13431. Epub 2022 Feb 1.
4
How Do Clinicians of Different Specialties Perceive and Use Opioid Risk Mitigation Strategies? A Qualitative Study.
Subst Use Misuse. 2021;56(9):1352-1362. doi: 10.1080/10826084.2021.1926514. Epub 2021 May 22.
5
Predictors of pharmacists' likelihood to query prescription drug monitoring program databases.
J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):614-622.e3. doi: 10.1016/j.japh.2021.04.019. Epub 2021 Apr 30.
9
A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy.
Am J Public Health. 2020 Aug;110(8):1191-1197. doi: 10.2105/AJPH.2020.305696. Epub 2020 Jun 18.
10
Improving the design of California's prescription drug monitoring program.
JAMIA Open. 2019 Jan 28;2(1):160-172. doi: 10.1093/jamiaopen/ooy064. eCollection 2019 Apr.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验